What is a stock summary page? Click here for an overview.
Business Description
T2 Biosystems Inc
NAICS : 325413
SIC : 2835
ISIN : US89853L1044
Description
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | -0.65 | |||||
| Debt-to-Equity | -1.62 | |||||
| Debt-to-EBITDA | -0.48 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -55.51 | |||||
| Beneish M-Score | -3.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -84.6 | |||||
| 3-Year EBITDA Growth Rate | 78 | |||||
| 3-Year EPS without NRI Growth Rate | 78.2 | |||||
| 3-Year FCF Growth Rate | 78.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 66.91 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 71.19 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.92 | |||||
| 9-Day RSI | 49.83 | |||||
| 14-Day RSI | 45.84 | |||||
| 3-1 Month Momentum % | -69.51 | |||||
| 6-1 Month Momentum % | -93.13 | |||||
| 12-1 Month Momentum % | -95.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | |||||
| Quick Ratio | 0.24 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 122.46 | |||||
| Days Sales Outstanding | 71.1 | |||||
| Days Payable | 55.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.9 | |||||
| Shareholder Yield % | 266.66 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -76.76 | |||||
| Operating Margin % | -542.6 | |||||
| Net Margin % | -559.52 | |||||
| FCF Margin % | -476.98 | |||||
| ROA % | -150.57 | |||||
| ROIC % | -99.24 | |||||
| 3-Year ROIIC % | -22.25 | |||||
| ROC (Joel Greenblatt) % | -453.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.12 | |||||
| EV-to-EBIT | -0.51 | |||||
| EV-to-Forward-EBIT | -1.06 | |||||
| EV-to-EBITDA | -0.51 | |||||
| EV-to-Revenue | 2.63 | |||||
| EV-to-Forward-Revenue | 1.78 | |||||
| EV-to-FCF | -0.54 | |||||
| Price-to-GF-Value | 0.58 | |||||
| Price-to-Median-PS-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -196.08 | |||||
| FCF Yield % | -1078.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TTOO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
T2 Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 7.677 | ||
| EPS (TTM) ($) | -6.418 | ||
| Beta | 13.66 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 3.19 | ||
| Volatility % | 108.34 | ||
| 14-Day RSI | 45.84 | ||
| 14-Day ATR ($) | 0.023592 | ||
| 20-Day SMA ($) | 0.12097 | ||
| 12-1 Month Momentum % | -95.63 | ||
| 52-Week Range ($) | 0.056 - 6.8 | ||
| Shares Outstanding (Mil) | 28.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
T2 Biosystems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
T2 Biosystems Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
T2 Biosystems Inc Frequently Asked Questions
What is T2 Biosystems Inc(TTOO)'s stock price today?
The current price of TTOO is $0.12. The 52 week high of TTOO is $6.80 and 52 week low is $0.06.
When is next earnings date of T2 Biosystems Inc(TTOO)?
The next earnings date of T2 Biosystems Inc(TTOO) is 2025-05-06 Est..
Does T2 Biosystems Inc(TTOO) pay dividends? If so, how much?
T2 Biosystems Inc(TTOO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers